tradingkey.logo

Integra Lifesciences Holdings Corp

IART
查看詳細走勢圖
11.260USD
+0.380+3.49%
收盤 02/06, 16:00美東報價延遲15分鐘
876.42M總市值
虧損本益比TTM

Integra Lifesciences Holdings Corp

11.260
+0.380+3.49%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+3.49%

5天

+1.08%

1月

-18.76%

6月

-13.12%

今年開始到現在

-9.34%

1年

-55.35%

查看詳細走勢圖

操作建議

Integra Lifesciences Holdings Corp當前公司基本面數據相對穩定,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名78/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為15.50。中期看,股價處於平穩狀態。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Integra Lifesciences Holdings Corp評分

相關信息

行業排名
78 / 205
全市場排名
213 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Integra Lifesciences Holdings Corp亮點

亮點風險
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
業績轉虧
公司業績轉虧,最新年度虧損美元
估值合理
公司最新PE估值-1.74,處於3年歷史合理位
機構減倉
最新機構持股75.09M股,環比減少24.73%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉7.12M股

分析師目標

基於 12 分析師
持有
評級
15.500
目標均價
+37.66%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Integra Lifesciences Holdings Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Integra Lifesciences Holdings Corp簡介

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
公司代碼IART
公司Integra Lifesciences Holdings Corp
CEOPoul (Mojdeh)
網址https://www.integralife.com/
KeyAI